Los puntos clave no están disponibles para este artículo en este momento.
DHX9 loss decreases tumor growth, induces immune cell infiltration and enhances response to immunotherapy
Murayama et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: